Institutional Repository of Vilnius University
Cirkuliuojančių miRNR analizė nėščiųjų diabetu sergančių moterų kraujyje /
Abstract
dc:descriptionVILNIUS UNIVERSITY Life Sciences Center Institute of Biosciences GABRIELĖ DZIMITRAVIČIŪTĖ Analysis of circulating miRNA in blood of women diagnosed with gestational diabetes Bachelor Thesis SUMMARY Gestational diabetes (GD) is a chronic hyperglycemia diagnosed during the 2nd trimester of pregnancy. Even though GD usually disappears after delivery, it is associated with higher risk of T2D for both mother and her child. Therefore, it is necessary to elucidate the epigenetic biomarkers for GD and T2D risk. In this study miR-16-5p, miR-27a-3p, miR-152-3p, miR-155-5p, miR-222-3p and miR-518d-5p were analyzed using real-time PCR in whole-blood samples, taken during 24–28 weeks of pregnancy, 6–12 weeks after delivery and from umbilical artery and vein from women diagnosed with GD, and analyzed according to clinical parameters. Higher amounts of miR-16-5p, miR-152-3p, miR-155-5p and miR-222-3p were detected in blood of GD women after delivery as compared to gestational period (all p < 0.05), while higher amounts of miR-16-5p, miR-27a-3p and miR-152-3p were detected in blood of GD women after delivery in comparison to healthy non-pregnant women (all p < 0.05). MiRNA levels did not differ between the GD and non-GD women in blood during 24–28 weeks of the pregnancy (all p > 0.05). MiR-518d-5p was detected exceptionally in blood from umbilical artery, but the difference was not statistically significant (p > 0.05). In GD women, the amount of miR-16-5p in blood at 24–28 weeks of pregnancy was associated with BMI before pregnancy, while amounts of miR-27a-3p and miR-155-5p correlated with PG (all p > 0.05). The amount of miR-155-5p in blood after delivery was associated with age and similar associations were detected for miR-16-5p and miR-222-3p in blood from umbilical vein (all p < 0.05). This study showed various associations between the amounts of tested miRNAs in blood of GD positive women and their clinical parameters. However, comprehensive studies are needed to evaluate the potential of these miRNAs as GD biomarkers.
Degree
thesis:*- Grantor dc:publisher
- Institutional Repository of Vilnius University
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Dzimitravičiūtė, Gabrielė,
Rights
dc:rights- Statement dc:rights
-
- info:eu-repo/semantics/openAccess
- Language dc:language
- lit
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://repository.vu.lt/VU:ELABAETD193302873&prefLang=en_US